Літій (медичне застосування) (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Літій (медичне застосування)" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

60nih.gov

4^th place

5^th place

46doi.org

2^nd place

4^th place

10web.archive.org

1^st place

6archive.org

6^th place

4books.google.com

3^rd place

11^th place

3worldcat.org

5^th place

9^th place

2drugs.com

399^th place

754^th place

2who.int

195^th place

71^st place

2clincalc.com

3,912^th place

low place

1aafp.org

1,916^th place

726^th place

1fda.gov

447^th place

906^th place

1archive.today

14^th place

18^th place

1loc.gov

70^th place

91^st place

1ajgponline.org

low place

1semanticscholar.org

11^th place

964^th place

1medscape.com

719^th place

441^st place

1tga.gov.au

3,984^th place

low place

1evidence.nhs.uk

low place

1webmd.com

1,169^th place

1,358^th place

1uptodate.com

3,771^st place

9,019^th place

1inhn.org

low place

1news.google.com

59^th place

955^th place

aafp.org

Armstrong C (15 вересня 2008). ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation. American Family Physician. 78 (6): 772. ISSN 0002-838X.

ajgponline.org

Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 березня 2023). Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. The American Journal of Geriatric Psychiatry (English) . 31 (9): 716—725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815.

archive.org

Lenox RH, Watson DG (February 1994). Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clinical Chemistry. 40 (2): 309—314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A та ін. (June 2009). Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. The Journal of Clinical Psychiatry. 70 (6): 922—931. doi:10.4088/JCP.08m04606. PMID 19573486.
Disposition of Toxic Drugs and Chemicals in Man (вид. 8th). Foster City, CA: Biomedical Publications. 2008. с. 851–854. ISBN 978-0-9626523-7-0.
Joint Formulary Committee (2013). British National Formulary (BNF) 65. London, UK: Pharmaceutical Press. с. 240–242. ISBN 9780857110848.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). Renal failure occurs in chronic lithium treatment but is uncommon. Kidney International. 77 (3): 219—224. doi:10.1038/ki.2009.433. PMID 19940841.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H та ін. (August 2003). Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney International. 64 (2): 585—592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.

archive.today

Lithium Carbonate Medication Guide (PDF). U.S. FDA. Архів (PDF) оригіналу за 27 January 2022. Процитовано 27 січня 2022.

books.google.com

Drug discovery : a history (вид. Rev. and updated). Chichester: Wiley. 2005. с. 63. ISBN 9780471899792. Архів оригіналу за 8 September 2017.
Lithium: its clinical uses and biological mechanisms of action. The Brain, Biochemistry, and Behavior: Proceedings of the Sixth Arnold O. Beckman Conference in Clinical Chemistry (англ.). American Association for Clinical Chemistry. 1984. с. 170. ISBN 978-0-915274-22-2.
Lithium in Neuropsychiatry: The Comprehensive Guide. Taylor & Francis. 2006. ISBN 978-1-84184-515-9. Процитовано 17 липня 2021.
Lithium and the Cell: Pharmacology and Biochemistry. Academic Press. 2 грудня 2012. ISBN 9780080984292.

clincalc.com

The Top 300 of 2020. ClinCalc. Процитовано 7 жовтня 2022.
Lithium – Drug Usage Statistics. ClinCalc. Процитовано 7 жовтня 2022.

doi.org

Lenox RH, Watson DG (February 1994). Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clinical Chemistry. 40 (2): 309—314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 березня 2023). Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. The American Journal of Geriatric Psychiatry (English) . 31 (9): 716—725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815.
Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (April 2014). Role of lithium augmentation in the management of major depressive disorder. CNS Drugs. 28 (4): 331—342. doi:10.1007/s40263-014-0152-8. PMID 24590663.
Shorter E (June 2009). The history of lithium therapy. Bipolar Disorders. 11 (Suppl 2): 4—9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). Lithium for acute mania. The Cochrane Database of Systematic Reviews. 6 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Rakofsky JJ, Lucido MJ, Dunlop BW (July 2022). Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis. Journal of Affective Disorders. 308: 268—280. doi:10.1016/j.jad.2022.04.058. PMID 35429528.
Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M (September 2023). Lithium in bipolar depression: A review of the evidence. Human Psychopharmacology. 38 (5): e2881. doi:10.1002/hup.2881. PMID 37789577.
Cai L, Chen G, Yang H, Bai Y (July 2023). Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology. 38 (4): 249—260. doi:10.1097/YIC.0000000000000449. PMID 36947416.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF та ін. (May 2022). Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. European Neuropsychopharmacology. 58: 20—29. doi:10.1016/j.euroneuro.2022.01.112. PMID 35158229.
Rosenberg JM, Salzman C (November 2007). Update: new uses for lithium and anticonvulsants. CNS Spectrums. 12 (11): 831—841. doi:10.1017/S1092852900015571. PMID 17984856.
Frye MA, Salloum IM (December 2006). Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders. 8 (6): 677—685. doi:10.1111/j.1399-5618.2006.00370.x. PMID 17156154.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMID 36111461.
Treatment of Depression with Lithium. The Essential Guide to Lithium Treatment. Springer International Publishing. 2016. с. 71—80. doi:10.1007/978-3-319-31214-9_7. ISBN 978-3-319-31212-5.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G та ін. (September 2020). Lithium and suicide prevention in mood disorders and in the general population: A systematic review. Neuroscience and Biobehavioral Reviews. 116: 142—153. doi:10.1016/j.neubiorev.2020.06.017. PMID 32561344.
Börjesson J, Gøtzsche PC (September 2019). Effect of lithium on suicide and mortality in mood disorders: a systematic review. The International Journal of Risk & Safety in Medicine. 30 (3): 155—166. doi:10.3233/JRS-190058. PMID 31381531.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials. BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Cipriani A, Hawton K, Stockton S, Geddes JR (June 2013). Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 346: f3646. doi:10.1136/bmj.f3646. PMID 23814104.
Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (October 2006). Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders. 8 (5p2): 625—639. doi:10.1111/j.1399-5618.2006.00344.x. PMID 17042835.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE та ін. (April 2021). Alzheimer's disease. Lancet. 397 (10284): 1577—1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?. Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19. European Review for Medical and Pharmacological Sciences. 26 (6): 2201—2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A та ін. (June 2009). Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. The Journal of Clinical Psychiatry. 70 (6): 922—931. doi:10.4088/JCP.08m04606. PMID 19573486.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?. Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.
Amdisen A (1978). Clinical and serum level monitoring in lithium therapy and lithium intoxication. Journal of Analytical Toxicology. 2 (5): 193—202. doi:10.1093/jat/2.5.193.
Gutwinski S, Fierley L, Schreiter S, Bermpohl F, Heinz A, Henssler J (October 2021). [Lithium Withdrawal Symptoms – A Systematic Review]. Psychiatrische Praxis (нім.). Georg Thieme Verlag KG. 48 (7): 341—350. doi:10.1055/a-1481-1953. PMID 34015856.
Gitlin M (December 2016). Lithium side effects and toxicity: prevalence and management strategies. International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Yazici O, Kora K, Polat A, Saylan M (June 2004). Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis. Journal of Affective Disorders. 80 (2–3): 269—271. doi:10.1016/S0165-0327(03)00133-2. PMID 15207941.
Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J (May 2015). Effects of 10 to 30 years of lithium treatment on kidney function. Journal of Psychopharmacology. 29 (5): 608—614. doi:10.1177/0269881115573808. PMID 25735990.
Baek JH, Kinrys G, Nierenberg AA (January 2014). Lithium tremor revisited: pathophysiology and treatment. Acta Psychiatrica Scandinavica. Wiley. 129 (1): 17—23. doi:10.1111/acps.12171. PMID 23834617.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K (January 2011). Drug-induced hypoglycaemia: an update. Drug Safety. Springer Science and Business Media LLC. 34 (1): 21—45. doi:10.2165/11538290-000000000-00000. PMID 20942513.
Malhi GS, Tanious M, Bargh D, Das P, Berk M (2013). Safe and effective use of lithium. Australian Prescriber. 36: 18—21. doi:10.18773/austprescr.2013.008.
Rissardo JP, Caprara AL, Durante Í, Rauber A (2022). Lithium-associated movement disorder: A literature review. Brain Circulation. 8 (2): 76—86. doi:10.4103/bc.bc_77_21. PMC 9336594. PMID 35909709.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). Renal failure occurs in chronic lithium treatment but is uncommon. Kidney International. 77 (3): 219—224. doi:10.1038/ki.2009.433. PMID 19940841.
Davis J, Desmond M, Berk M (October 2018). Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal. Nephrology. Wiley. 23 (10): 897—903. doi:10.1111/nep.13263. PMID 29607573.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H та ін. (August 2003). Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney International. 64 (2): 585—592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.
Finley PR, O'Brien JG, Coleman RW (February 1996). Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. Journal of Clinical Psychopharmacology. 16 (1): 68—71. doi:10.1097/00004714-199602000-00011. PMID 8834421.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (September 2021). Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. 54 (5): 240—245. doi:10.1055/a-1524-2794. PMID 34348413.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Scheuch K, Höltje M, Budde H, Lautenschlager M, Heinz A, Ahnert-Hilger G, Priller J (January 2010). Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons. Brain Research. 1307: 14—21. doi:10.1016/j.brainres.2009.10.027. PMID 19840776.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 27 (2): 135—153. doi:10.1007/s40263-013-0039-0. PMID 23371914.
Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK (February 2021). Novel mechanism of action for the mood stabilizer lithium. Bipolar Disorders. 23 (1): 76—83. doi:10.1111/bdi.13019. PMID 33037686.
Cade JF (September 1949). Lithium salts in the treatment of psychotic excitement (PDF). The Medical Journal of Australia. 2 (10): 349—352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Архів (PDF) оригіналу за 25 травня 2006.
Ludolph AC, Brettschneider J, Weishaupt JH (October 2012). Amyotrophic lateral sclerosis. Current Opinion in Neurology. 25 (5): 530—535. doi:10.1097/WCO.0b013e328356d328. PMID 22918486.

drugs.com

Lithium brands. Drugs.com. Архів оригіналу за 5 квітня 2017. Процитовано 4 квітня 2017.
Lithium Salts. The American Society of Health-System Pharmacists. Архів оригіналу за 8 December 2015. Процитовано 1 грудня 2015.

evidence.nhs.uk

Lithium carbonate. Архів оригіналу за 25 October 2016. Процитовано 25 травня 2016.

fda.gov

accessdata.fda.gov

Lithium Carbonate Medication Guide (PDF). U.S. FDA. Архів (PDF) оригіналу за 27 January 2022. Процитовано 27 січня 2022.

inhn.org

Lithium: Discovered, Forgotten and Rediscovered. inhn.org. Процитовано 12 березня 2023.

loc.gov

webarchive.loc.gov

Mitchell PB, Hadzi-Pavlovic D (2000). Lithium treatment for bipolar disorder (PDF). Bulletin of the World Health Organization. 78 (4): 515—517. PMC 2560742. PMID 10885179. Архів оригіналу (PDF) за 1 квітня 2012.

medscape.com

reference.medscape.com

lithium (Rx) - Eskalith, Lithobid. Medscape. WebMD. Архів оригіналу за 4 December 2013. Процитовано 7 жовтня 2013.

news.google.com

anonymous (13 липня 1950). ISALLY'S (ad). Painesville Telegraph. Процитовано 8 вересня 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Lenox RH, Watson DG (February 1994). Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness. Clinical Chemistry. 40 (2): 309—314. doi:10.1093/clinchem/40.2.309. PMID 8313612.
Mitchell PB, Hadzi-Pavlovic D (2000). Lithium treatment for bipolar disorder (PDF). Bulletin of the World Health Organization. 78 (4): 515—517. PMC 2560742. PMID 10885179. Архів оригіналу (PDF) за 1 квітня 2012.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 березня 2023). Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. The American Journal of Geriatric Psychiatry (English) . 31 (9): 716—725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815.
Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (April 2014). Role of lithium augmentation in the management of major depressive disorder. CNS Drugs. 28 (4): 331—342. doi:10.1007/s40263-014-0152-8. PMID 24590663.
Shorter E (June 2009). The history of lithium therapy. Bipolar Disorders. 11 (Suppl 2): 4—9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). Lithium for acute mania. The Cochrane Database of Systematic Reviews. 6 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Rakofsky JJ, Lucido MJ, Dunlop BW (July 2022). Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis. Journal of Affective Disorders. 308: 268—280. doi:10.1016/j.jad.2022.04.058. PMID 35429528.
Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M (September 2023). Lithium in bipolar depression: A review of the evidence. Human Psychopharmacology. 38 (5): e2881. doi:10.1002/hup.2881. PMID 37789577.
Cai L, Chen G, Yang H, Bai Y (July 2023). Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology. 38 (4): 249—260. doi:10.1097/YIC.0000000000000449. PMID 36947416.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF та ін. (May 2022). Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. European Neuropsychopharmacology. 58: 20—29. doi:10.1016/j.euroneuro.2022.01.112. PMID 35158229.
Rosenberg JM, Salzman C (November 2007). Update: new uses for lithium and anticonvulsants. CNS Spectrums. 12 (11): 831—841. doi:10.1017/S1092852900015571. PMID 17984856.
Frye MA, Salloum IM (December 2006). Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders. 8 (6): 677—685. doi:10.1111/j.1399-5618.2006.00370.x. PMID 17156154.
Vornik LA, Brown ES (2006). Management of comorbid bipolar disorder and substance abuse. The Journal of Clinical Psychiatry. 67 (Suppl 7): 24—30. PMID 16961421.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMID 36111461.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G та ін. (September 2020). Lithium and suicide prevention in mood disorders and in the general population: A systematic review. Neuroscience and Biobehavioral Reviews. 116: 142—153. doi:10.1016/j.neubiorev.2020.06.017. PMID 32561344.
Börjesson J, Gøtzsche PC (September 2019). Effect of lithium on suicide and mortality in mood disorders: a systematic review. The International Journal of Risk & Safety in Medicine. 30 (3): 155—166. doi:10.3233/JRS-190058. PMID 31381531.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials. BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Cipriani A, Hawton K, Stockton S, Geddes JR (June 2013). Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 346: f3646. doi:10.1136/bmj.f3646. PMID 23814104.
Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (October 2006). Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders. 8 (5p2): 625—639. doi:10.1111/j.1399-5618.2006.00344.x. PMID 17042835.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE та ін. (April 2021). Alzheimer's disease. Lancet. 397 (10284): 1577—1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?. Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19. European Review for Medical and Pharmacological Sciences. 26 (6): 2201—2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Hampel H, Ewers M, Bürger K, Annas P, Mörtberg A, Bogstedt A та ін. (June 2009). Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. The Journal of Clinical Psychiatry. 70 (6): 922—931. doi:10.4088/JCP.08m04606. PMID 19573486.
Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?. Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.
Gutwinski S, Fierley L, Schreiter S, Bermpohl F, Heinz A, Henssler J (October 2021). [Lithium Withdrawal Symptoms – A Systematic Review]. Psychiatrische Praxis (нім.). Georg Thieme Verlag KG. 48 (7): 341—350. doi:10.1055/a-1481-1953. PMID 34015856.
Gitlin M (December 2016). Lithium side effects and toxicity: prevalence and management strategies. International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Yazici O, Kora K, Polat A, Saylan M (June 2004). Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis. Journal of Affective Disorders. 80 (2–3): 269—271. doi:10.1016/S0165-0327(03)00133-2. PMID 15207941.
Aiff H, Attman PO, Aurell M, Bendz H, Ramsauer B, Schön S, Svedlund J (May 2015). Effects of 10 to 30 years of lithium treatment on kidney function. Journal of Psychopharmacology. 29 (5): 608—614. doi:10.1177/0269881115573808. PMID 25735990.
Baek JH, Kinrys G, Nierenberg AA (January 2014). Lithium tremor revisited: pathophysiology and treatment. Acta Psychiatrica Scandinavica. Wiley. 129 (1): 17—23. doi:10.1111/acps.12171. PMID 23834617.
Ben Salem C, Fathallah N, Hmouda H, Bouraoui K (January 2011). Drug-induced hypoglycaemia: an update. Drug Safety. Springer Science and Business Media LLC. 34 (1): 21—45. doi:10.2165/11538290-000000000-00000. PMID 20942513.
Rissardo JP, Caprara AL, Durante Í, Rauber A (2022). Lithium-associated movement disorder: A literature review. Brain Circulation. 8 (2): 76—86. doi:10.4103/bc.bc_77_21. PMC 9336594. PMID 35909709.
Bendz H, Schön S, Attman PO, Aurell M (February 2010). Renal failure occurs in chronic lithium treatment but is uncommon. Kidney International. 77 (3): 219—224. doi:10.1038/ki.2009.433. PMID 19940841.
Davis J, Desmond M, Berk M (October 2018). Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal. Nephrology. Wiley. 23 (10): 897—903. doi:10.1111/nep.13263. PMID 29607573.
Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H та ін. (August 2003). Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney International. 64 (2): 585—592. doi:10.1046/j.1523-1755.2003.00096.x. PMID 12846754.
Finley PR, O'Brien JG, Coleman RW (February 1996). Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. Journal of Clinical Psychopharmacology. 16 (1): 68—71. doi:10.1097/00004714-199602000-00011. PMID 8834421.
Emilien G, Maloteaux JM (December 1996). Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Acta Neurologica Belgica. 96 (4): 281—293. PMID 9008777.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR (September 2021). Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. 54 (5): 240—245. doi:10.1055/a-1524-2794. PMID 34348413.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Scheuch K, Höltje M, Budde H, Lautenschlager M, Heinz A, Ahnert-Hilger G, Priller J (January 2010). Lithium modulates tryptophan hydroxylase 2 gene expression and serotonin release in primary cultures of serotonergic raphe neurons. Brain Research. 1307: 14—21. doi:10.1016/j.brainres.2009.10.027. PMID 19840776.
Malhi GS, Tanious M, Das P, Coulston CM, Berk M (February 2013). Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 27 (2): 135—153. doi:10.1007/s40263-013-0039-0. PMID 23371914.
Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK (February 2021). Novel mechanism of action for the mood stabilizer lithium. Bipolar Disorders. 23 (1): 76—83. doi:10.1111/bdi.13019. PMID 33037686.
Cade JF (September 1949). Lithium salts in the treatment of psychotic excitement (PDF). The Medical Journal of Australia. 2 (10): 349—352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Архів (PDF) оригіналу за 25 травня 2006.
Ludolph AC, Brettschneider J, Weishaupt JH (October 2012). Amyotrophic lateral sclerosis. Current Opinion in Neurology. 25 (5): 530—535. doi:10.1097/WCO.0b013e328356d328. PMID 22918486.

ncbi.nlm.nih.gov

Mitchell PB, Hadzi-Pavlovic D (2000). Lithium treatment for bipolar disorder (PDF). Bulletin of the World Health Organization. 78 (4): 515—517. PMC 2560742. PMID 10885179. Архів оригіналу (PDF) за 1 квітня 2012.
Shorter E (June 2009). The history of lithium therapy. Bipolar Disorders. 11 (Suppl 2): 4—9. doi:10.1111/j.1399-5618.2009.00706.x. PMC 3712976. PMID 19538681.
McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A (June 2019). Lithium for acute mania. The Cochrane Database of Systematic Reviews. 6 (6): CD004048. doi:10.1002/14651858.CD004048.pub4. PMC 6544558. PMID 31152444.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J (September 2022). Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiology and Psychiatric Sciences. 31: e65. doi:10.1017/S204579602200049X. PMC 9533115. PMID 36111461.
Riblet NV, Shiner B, Young-Xu Y, Watts BV (November 2022). Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials. BJPsych Open. 8 (6): e199. doi:10.1192/bjo.2022.605. PMC 9707499. PMID 36384820.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE та ін. (April 2021). Alzheimer's disease. Lancet. 397 (10284): 1577—1590. doi:10.1016/S0140-6736(20)32205-4. PMC 8354300. PMID 33667416.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM (March 2022). Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19. European Review for Medical and Pharmacological Sciences. 26 (6): 2201—2214. doi:10.26355/eurrev_202203_28369. PMC 9173589. PMID 35363371.
Gitlin M (December 2016). Lithium side effects and toxicity: prevalence and management strategies. International Journal of Bipolar Disorders. 4 (1): 27. doi:10.1186/s40345-016-0068-y. PMC 5164879. PMID 27900734.
Davis J, Desmond M, Berk M (November 2018). Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrology. Springer Science and Business Media LLC. 19 (1): 305. doi:10.1186/s12882-018-1101-4. PMC 6215627. PMID 30390660.
Rissardo JP, Caprara AL, Durante Í, Rauber A (2022). Lithium-associated movement disorder: A literature review. Brain Circulation. 8 (2): 76—86. doi:10.4103/bc.bc_77_21. PMC 9336594. PMID 35909709.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1): PCC.11r01197. doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Netto I, Phutane VH (2012). Reversible lithium neurotoxicity: review of the literatur. The Primary Care Companion for CNS Disorders. 14 (1). doi:10.4088/PCC.11r01197. PMC 3357580. PMID 22690368.
Cade JF (September 1949). Lithium salts in the treatment of psychotic excitement (PDF). The Medical Journal of Australia. 2 (10): 349—352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Архів (PDF) оригіналу за 25 травня 2006.

dailymed.nlm.nih.gov

Lithobid (lithium carbonate) tablet, film coated, extended release. Noven Therapeutics, LLC. National Library of Medicine. Архів оригіналу за 5 October 2013. Процитовано 7 жовтня 2013.

semanticscholar.org

api.semanticscholar.org

Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (August 2021). Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?. Neuroscience Letters. 760: 136044. doi:10.1016/j.neulet.2021.136044. PMID 34119602. S2CID 235385875.

tga.gov.au

ebs.tga.gov.au

Product Information Lithicarb (Lithium carbonate). TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. Архів оригіналу за 22 March 2017. Процитовано 7 жовтня 2013.

uptodate.com

Neuroleptic malignant syndrome. UpToDate. Wolters Kluwer. Архів оригіналу за 23 October 2013. Процитовано 8 жовтня 2013.

web.archive.org

Lithium brands. Drugs.com. Архів оригіналу за 5 квітня 2017. Процитовано 4 квітня 2017.
Lithium Salts. The American Society of Health-System Pharmacists. Архів оригіналу за 8 December 2015. Процитовано 1 грудня 2015.
Drug discovery : a history (вид. Rev. and updated). Chichester: Wiley. 2005. с. 63. ISBN 9780471899792. Архів оригіналу за 8 September 2017.
lithium (Rx) - Eskalith, Lithobid. Medscape. WebMD. Архів оригіналу за 4 December 2013. Процитовано 7 жовтня 2013.
Lithobid (lithium carbonate) tablet, film coated, extended release. Noven Therapeutics, LLC. National Library of Medicine. Архів оригіналу за 5 October 2013. Процитовано 7 жовтня 2013.
Product Information Lithicarb (Lithium carbonate). TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. Архів оригіналу за 22 March 2017. Процитовано 7 жовтня 2013.
Lithium carbonate. Архів оригіналу за 25 October 2016. Процитовано 25 травня 2016.
Lithium. WebMD. Архів оригіналу за 2 November 2014. Процитовано 1 листопада 2014.
Neuroleptic malignant syndrome. UpToDate. Wolters Kluwer. Архів оригіналу за 23 October 2013. Процитовано 8 жовтня 2013.
Cade JF (September 1949). Lithium salts in the treatment of psychotic excitement (PDF). The Medical Journal of Australia. 2 (10): 349—352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Архів (PDF) оригіналу за 25 травня 2006.

webmd.com

Lithium. WebMD. Архів оригіналу за 2 November 2014. Процитовано 1 листопада 2014.

who.int

Mitchell PB, Hadzi-Pavlovic D (2000). Lithium treatment for bipolar disorder (PDF). Bulletin of the World Health Organization. 78 (4): 515—517. PMC 2560742. PMID 10885179. Архів оригіналу (PDF) за 1 квітня 2012.
Cade JF (September 1949). Lithium salts in the treatment of psychotic excitement (PDF). The Medical Journal of Australia. 2 (10): 349—352. doi:10.1080/j.1440-1614.1999.06241.x. PMC 2560740. PMID 18142718. Архів (PDF) оригіналу за 25 травня 2006.

worldcat.org

search.worldcat.org

Armstrong C (15 вересня 2008). ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation. American Family Physician. 78 (6): 772. ISSN 0002-838X.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A (27 березня 2023). Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. The American Journal of Geriatric Psychiatry (English) . 31 (9): 716—725. doi:10.1016/j.jagp.2023.03.012. ISSN 1064-7481. PMID 37080815.
The Science and Practice of Lithium Therapy. Springer International Publishing. 2017. с. 61. ISBN 9783319459233. OCLC 979600268.